MDSO News 51.95 Medidata Solutions (MDSO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medidata Solutions (MDSO) 51.95 $MDSO

Shares of MDSO Down 7.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 17, 11:19AM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 3 weeks, Medidata Solutions has returned 7.52% as of today's recent price of $52.24.

Theorem Clinical Research Expands Partnership with Medidata Solutions
Business Wire - Thu Apr 17, 7:01AM CDT
Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud(TM).

Insider Trading Alert - JAZZ, GDOT And MDSO Traded By Insiders
at The Street - Fri Apr 11, 9:15AM CDT
Stocks with insider trader activity include JAZZ, GDOT and MDSO

Shares of MDSO Down 13.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Apr 10, 10:00AM CDT
SmarTrend identified a Downtrend for Medidata Solutions (NASDAQ:MDSO) on March 26th, 2014 at $56.49. In approximately 2 weeks, Medidata Solutions has returned 13.39% as of today's recent price of $48.92.

Medidata Schedules First Quarter Earnings Conference Call for April 22, 2014
Business Wire - Wed Apr 09, 7:30AM CDT
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it will release its first quarter 2014 financial results before the open of the market on Tuesday, April 22, 2014. Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss the Company's results and business outlook.

Insider Trading Alert - IMPV, MDSO And IPGP Traded By Insiders
at The Street - Tue Apr 08, 9:15AM CDT
Stocks with insider trader activity include IMPV, MDSO and IPGP

Medidata to Present at Piper Jaffray Technology, Media & Telecommunications Conference
Business Wire - Wed Mar 05, 7:30AM CST
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the Piper Jaffray Technology, Media & Telecommunications Conference on March 12, 2014, at 2:00 p.m. ET in New York.

Akorn, Questcor, Parexel Among Top Medical Small Caps
at Investor's Business Daily - Thu Feb 27, 7:02AM CST
The health care industry is rapidly changing with new advances in medicine. Many of the most promising novel advancements are coming from smaller companies, which are more nimble and quicker to change. Medicine and health care-related stocks Akorn...

Form 4: Update Filing for Medidata Solutions Inc (MDSO)
Vickers Stock Research - Wed Feb 26, 8:42AM CST
- The world's first dual mode HD voice over LTE call between TD-LTE and LTE FDD demonstrated

Zacks Investment Ideas feature highlights: Amazon, Medidata Solutions, Qualys and LinkedIn
PR Newswire - Tue Feb 25, 8:30AM CST
Today, Zacks Investment Ideas feature highlights Features: Amazon (Nasdaq:AMZN-Free Report), Medidata Solutions (Nasdaq:MDSO-Free Report), Qualys (Nasdaq:QLYS-Free Report) and LinkedIn (NYSE:LNKD-Free Report).

Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference
Business Wire - Tue Feb 25, 7:30AM CST
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Tarek Sherif, chief executive officer, and Cory Douglas, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on March 3, 2014, at 3:25 p.m. PT (6:25 p.m. ET) in San Francisco.

4 Expensive Stocks to Avoid - Investment Ideas
Todd Bunton - Zacks Investment Research - Mon Feb 24, 5:01PM CST
4 Expensive Stocks to Avoid - Investment Ideas

Were Medidata Solutions Inc Earnings Really That Bad?
Brian Stoffel, The Motley Fool - Motley Fool - Wed Feb 12, 5:30PM CST
Last week, Medidata Solutions Inc came out with earnings that appeared excellent, and yet the stock lost about 20% of its value. Is this something investors should really worry about? As someone who bought   shares in August of last year, I'm not...

Insider Trading Alert - AINV, LLTC, ZION, MDSO And ABG Traded By Insiders
at The Street - Wed Feb 12, 10:00AM CST
Stocks with insider trader activity include AINV, LLTC, ZION, MDSO and ABG

3 Horrendous Health-Care Stocks This Week
Keith Speights, The Motley Fool - Motley Fool - Sat Feb 08, 7:00AM CST
What kind of week do you suppose Peyton Manning, star quarterback of the Denver Broncos, had this week? After the horrible Super Bowl loss to the Seattle Seahawks, it probably wasn't too great for Manning and the rest of the Denver team. ...

Why Medidata Solutions, Inc. Shares Dipped
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 06, 2:13PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Medidata Solutions , a developer of...

Medidata Solutions (MDSO) Shows Signs Of Being Water-Logged And Getting Wetter
at The Street - Thu Feb 06, 9:27AM CST
Trade-Ideas LLC identified Medidata Solutions (MDSO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

Medidata Reports Record Full Year and Fourth Quarter 2013 Results
Business Wire - Thu Feb 06, 5:30AM CST
--Record full year subscription revenue of $227.9 million, a 33% year-over-year increase

Medidata Solutions Set to Possibly Rebound After Yesterday's Selloff of 2.90%
Comtex SmarTrend(R) - Tue Feb 04, 6:04PM CST
Medidata Solutions (NASDAQ:MDSO) traded in a range yesterday that spanned from a low of $56.87 to a high of $61.39. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $58.16 on volume of 618,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 328

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 254

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 214

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 353

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 409

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Novartis Fabhalta® Breakthrough in PNH Treatment Showcased

Updated Category News Views 290

Novartis Fabhalta® Achieves Significant Hemoglobin Improvements In recent studies, Novartis has showcased promising results from its Phase IIIB APPULSE-PNH study regarding Fabhalta (iptacopan), designed for adult patients suffering from paroxysmal nocturnal hemoglobinuria (PNH). Patients who switched from anti-C5 therapies demonstrated noteworthy improvement in their...

Continue Reading
Insights into Indonesia's Economic Landscape for Credit Investors

Updated Category News Views 208

Understanding Indonesia's Market Dynamics This week, Gimme Credit unveiled a new Indonesia Country Report that delves into the recent fluctuations in the equity market and its potential ripple effects on foreign exchange and bond markets. The inquiry raises fundamental questions about whether these shifts could necessitate a higher risk premium for those investing in...

Continue Reading
Pliant Therapeutics to Showcase Innovations at Key Healthcare Conference

Updated Category News Views 187

Introduction to Pliant Therapeutics' Participation Pliant Therapeutics, Inc. (NASDAQ: PLRX), a dedicated force in the clinical-stage biotechnology sector, is set to make waves at an upcoming healthcare conference. The event serves as a platform for the company to showcase its integrin-based therapeutics—game-changing innovations aimed at treating various serious health...

Continue Reading
OSB Group PLC Financial Performance Overview for 2025

Updated Category News Views 322

OSB Group PLC Trading Update Summary OSB GROUP PLC, a specialist lending and retail savings group, is pleased to share its trading update for the nine-month period concluding on 30 September 2025. This report highlights the Group's steady growth and enhanced financial performance in line with expectations and strategic objectives. Performance Insights for the Nine-Month...

Continue Reading
Toll Brothers Unveils Luxurious Homes at Ridge Pointe Estates

Updated Category News Views 222

Toll Brothers Unveils New Luxury Homes at Ridge Pointe Estates Toll Brothers, Inc. (NYSE: TOL), recognized as a leader in the luxury home construction industry, has introduced its latest community, Ridge Pointe Estates. This community, now officially open, offers prospective homeowners a blend of elegance and modern living. Located within a serene setting, Ridge Pointe...

Continue Reading